Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs10059280 | chr5:50612871 | G/A | 7.07E-5 | 176 | 25.28 | 24.62 | 31.35 | KM Plot |
PCPG | rs10060580 | chr5:105190600 | A/G | 4.06E-6 | 170 | 26.38 | 31.2 | 24.37 | KM Plot |
PCPG | rs10062270 | chr5:105190749 | T/C | 4.06E-6 | 170 | 26.38 | 31.2 | 24.37 | KM Plot |
PCPG | rs10071749 | chr5:50601535 | T/C | 7.47E-5 | 176 | 25.08 | 24.62 | 31.35 | KM Plot |
PCPG | rs1007932 | chr16:89838541 | C/T | 0.000154 | 174 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs10089963 | chr8:126207277 | T/C | 0.000275 | 178 | 25.77 | 25.53 | 4.17 | KM Plot |
PCPG | rs10093813 | chr8:126217263 | C/T | 0.000275 | 178 | 25.77 | 25.53 | 4.17 | KM Plot |
PCPG | rs10093819 | chr8:126152375 | A/G | 0.000336 | 175 | 25.67 | 25.53 | 4.17 | KM Plot |
PCPG | rs10095101 | chr8:126235284 | A/G | 2.95E-5 | 178 | 25.35 | 28.3 | 4.17 | KM Plot |
PCPG | rs10096522 | chr8:126165278 | G/A | 3.56E-5 | 175 | 25.6 | 28.3 | 3.67 | KM Plot |
PCPG | rs10097122 | chr8:74271622 | T/G | 1.11E-16 | 172 | 25.28 | 26.57 | 3.17 | KM Plot |
PCPG | rs10097568 | chr8:126208921 | T/C | 0.000275 | 178 | 25.77 | 25.53 | 4.17 | KM Plot |
PCPG | rs10098862 | chr8:126206102 | A/G | 2.95E-5 | 178 | 25.35 | 28.3 | 4.17 | KM Plot |
PCPG | rs10102769 | chr8:126149315 | A/G | 3.22E-5 | 177 | 25.35 | 28.87 | 4.17 | KM Plot |
PCPG | rs10106909 | chr8:126228967 | T/C | 2.95E-5 | 178 | 25.35 | 28.3 | 4.17 | KM Plot |